Epithelial TMPRSS2 impairs glucose homeostasis in obese mice by regulating ghrelin-GLP-1 receptor signaling pathway

Dilraj Kaur1, Sagarika Chakrabarty2, Claudius Witzler1

  • 1Center for Thrombosis and Hemostasis (CTH), Medical Centre of the Johannes Gutenberg University, Mainz, Germany.

JCI Insight
|March 17, 2026
PubMed

Insights

Transmembrane serine protease 2 (TMPRSS2) in the gut deregulates incretin production, worsening obesity and glucose control. Inhibiting TMPRSS2 restores incretin signaling, offering a potential therapeutic target for obesity and related metabolic diseases.

Area of Science:

  • Gastroenterology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Glucagon-like peptide-1 (GLP-1) and glucose-induced insulinotropic polypeptide (GIP) receptor agonists are effective obesity treatments, but the causes of altered endogenous incretin production in obesity are unclear.
  • Intestinal epithelial cells (IECs) express proteases like TMPRSS2 and its target PAR2, which are implicated in metabolic regulation and inflammation.

Purpose of the Study:

  • To investigate the role of intestinal transmembrane serine protease 2 (TMPRSS2) in regulating endogenous incretin production and its impact on obesity and glucose homeostasis.
  • To explore TMPRSS2's mechanism of action via protease activated receptor 2 (PAR2) signaling in the gut.

Main Methods:

  • Utilized a PAR2 mutant mouse model resistant to TMPRSS2 cleavage.
  • Investigated the effects of pharmacological inhibition and genetic deletion of TMPRSS2 on incretin secretion and glucose homeostasis.
  • Assessed the impact of TMPRSS2 on ghrelin pathway bioavailability and GLP-1 signaling.

Main Results:

  • TMPRSS2 activates PAR2 in the gut, promoting postprandial GIP release and contributing to diet-induced obesity.
  • A PAR2 mutant mouse model resistant to TMPRSS2 was protected from GIP upregulation and obesity.
  • In obesity, TMPRSS2 impairs ghrelin pathway bioavailability, suppressing GLP-1 secretion and its glucose-lowering effects.
  • Inhibition or deletion of TMPRSS2 restored ghrelin-dependent GLP-1 secretion and anti-diabetic effects.

Conclusions:

  • Epithelial TMPRSS2 is a key regulator of intestinal incretins (GLP-1 and GIP), influencing obesity and glucose homeostasis.
  • TMPRSS2 represents a potential therapeutic target for metabolic diseases, linking gut health, infection (e.g., SARS-CoV-2), and cardiometabolic disorders.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.7K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.1K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.0K